Periodontitis impacts on thrombotic diseases: from clinical aspect to future therapeutic approaches

Abstract

Periodontitis is a chronic inflammatory disease initiated by biofilm microorganisms and mediated by host immune imbalance. Uncontrolled periodontal infections are the leading cause of tooth loss in adults. Thrombotic diseases can lead to partial or complete obstruction of blood flow in the circulatory system, manifesting as organ or tissue ischemia and necrosis in patients with arterial thrombosis, and local edema, pain and circulatory instability in patients with venous thrombosis, which may lead to mortality or fatality in severe case. Recent studies found that periodontitis might enhance thrombosis through bacterial transmission or systemic inflammation by affecting platelet-immune cell interactions, as well as the coagulation, and periodontal therapy could have a prophylactic effect on patients with thrombotic diseases. In this review, we summarized clinical findings on the association between periodontitis and thrombotic diseases and discussed several novel prothrombotic periodontitis-related agents, and presented a perspective to emphasize the necessity of oral health management for people at high risk of thrombosis.

References

[1.] HajishengallisG. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol., 2015, 15: 30-44

[2.] SlotsJ. Periodontitis: facts, fallacies and the future. Periodontol 2000, 2017, 75: 7-23

[3.] ChenMX, ZhongYJ, DongQQ, WongHM, WenYF. Global, regional, and national burden of severe periodontitis, 1990-2019: An analysis of the Global Burden of Disease Study 2019. J. Clin. Periodontol., 2021, 48: 1165-1188

[4.] Collaborators, G. B. D. O. D., et al. . Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017: A Systematic Analysis for the Global Burden of Disease 2017 Study. J. Dent. Res., 2020, 99: 362-373

[5.] ShoaeeS, et al. . Global, regional, and national burden and quality of care index (QCI) of oral disorders: a systematic analysis of the global burden of disease study 1990-2017. BMC Oral. Health, 2024, 24

[6.] KassebaumNJ, et al. . Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J. Dent. Res., 2014, 93: 1045-1053

[7.] SanzM, et al. . Periodontitis and cardiovascular diseases: Consensus report. J. Clin. Periodontol., 2020, 47: 268-288

[8.] Gonzalez-FeblesJ, SanzM. Periodontitis and rheumatoid arthritis: What have we learned about their connection and their treatment?. Periodontol 2000, 2021, 87: 181-203

[9.] WangZ, et al. . Association between inflammatory bowel disease and periodontitis: A bidirectional two-sample Mendelian randomization study. J. Clin. Periodontol., 2023, 50: 736-743

[10.] SuY, et al. . Periodontitis as a promoting factor of T2D: current evidence and mechanisms. Int J. Oral. Sci., 2023, 15: 25

[11.] ZhaoP, et al. . Hyperglycaemia-associated macrophage pyroptosis accelerates periodontal inflamm-aging. J. Clin. Periodontol., 2021, 48: 1379-1392

[12.] Sun, Y. et al. Intermittent hyperglycaemia induces macrophage dysfunction by extracellular regulated protein kinase-dependent PKM2 translocation in periodontitis. Cell Prolif, e13651 (2024).

[13.] TakeuchiK, et al. . Periodontitis Is Associated with Chronic Obstructive Pulmonary Disease. J. Dent. Res., 2019, 98: 534-540

[14.] ZhengS, et al. . Porphyromonas gingivalis survival skills: Immune evasion. J. Periodontal Res., 2021, 56: 1007-1018

[15.] LinS, et al. . Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. J. Periodontol., 2023, 94: 405-418

[16.] ZhuX, HuangH, ZhaoL. PAMPs and DAMPs as the Bridge Between Periodontitis and Atherosclerosis: The Potential Therapeutic Targets. Front Cell Dev. Biol., 2022, 10: 856118

[17.] ZhaoD, LiuJ, WangM, ZhangX, ZhouM. Epidemiology of cardiovascular disease in China: current features and implications. Nat. Rev. Cardiol., 2019, 16: 203-212

[18.] RothGA, et al. . Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol., 2017, 70: 1-25

[19.] MasaebiF, et al. . Trend analysis of disability adjusted life years due to cardiovascular diseases: results from the global burden of disease study 2019. BMC Public Health, 2021, 21

[20.] MensahGA, FusterV, RothGA. A Heart-Healthy and Stroke-Free World: Using Data to Inform Global Action. J. Am. Coll. Cardiol., 2023, 82: 2343-2349

[21.] OrlandiM, et al. . Association between periodontal disease and its treatment, flow-mediated dilatation and carotid intima-media thickness: a systematic review and meta-analysis. Atherosclerosis, 2014, 236: 39-46

[22.] HayashidaH, et al. . Association of periodontitis with carotid artery intima-media thickness and arterial stiffness in community-dwelling people in Japan: the Nagasaki Islands study. Atherosclerosis, 2013, 229: 186-191

[23.] DietrichT, SharmaP, WalterC, WestonP, BeckJ. The epidemiological evidence behind the association between periodontitis and incident atherosclerotic cardiovascular disease. J. Clin. Periodontol., 2013, 40: S70-S84

[24.] SenS, et al. . Periodontal Disease, Regular Dental Care Use, and Incident Ischemic. Stroke Stroke, 2018, 49: 355-362

[25.] YangS, et al. . Association between periodontitis and peripheral artery disease: a systematic review and meta-analysis. BMC Cardiovasc Disord., 2018, 18: 141

[26.] ChenDY, LinCH, ChenYM, ChenHH. Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study. PLoS One, 2016, 11: e0165601

[27.] MackmanN, BergmeierW, StoufferGA, WeitzJI. Therapeutic strategies for thrombosis: new targets and approaches. Nat. Rev. Drug Discov., 2020, 19: 333-352

[28.] StarkK, MassbergS. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol., 2021, 18: 666-682

[29.] Day, I. S. C. f. W. T.. Thrombosis: a major contributor to the global disease burden. J. Thromb. Haemost., 2014, 12: 1580-1590

[30.] AlkarithiG, DuvalC, ShiY, MacraeFL, AriensRAS. Thrombus Structural Composition in Cardiovascular Disease. Arterioscler Thromb. Vasc. Biol., 2021, 41: 2370-2383

[31.] ZabczykM, AriensRAS, UndasA. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovasc Res, 2023, 119: 94-111

[32.] WolbergAS, et al. . Venous thrombosis. Nat. Rev. Dis. Prim., 2015, 1: 15006

[33.] LoweGD. Common risk factors for both arterial and venous thrombosis. Br. J. Haematol., 2008, 140: 488-495

[34.] PrevitaliE, BucciarelliP, PassamontiSM, MartinelliI. Risk factors for venous and arterial thrombosis. Blood Transfus., 2011, 9: 120-138

[35.] BhatR, KwonS, ZanilettiI, MurthyK, LiemRI. Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: a multicentre case-control study. Lancet Haematol., 2022, 9: e200-e207

[36.] StollG, NieswandtB. Thrombo-inflammation in acute ischaemic stroke - implications for treatment. Nat. Rev. Neurol., 2019, 15: 473-481

[37.] van der MeijdenPEJ, HeemskerkJWM. Platelet biology and functions: new concepts and clinical perspectives. Nat. Rev. Cardiol., 2019, 16: 166-179

[38.] ToldoS, AbbateA. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat. Rev. Cardiol., 2024, 21: 219-237

[39.] ShiX, et al. . Heavy macrophage infiltration identified by optical coherence tomography relates to plaque rupture. Ann. Clin. Transl. Neurol., 2023, 10: 2334-2346

[40.] FoxEA, KahnSR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb. Haemost., 2005, 94: 362-365

[41.] PengX, et al. . Oral microbiota in human systematic diseases. Int J. Oral. Sci., 2022, 14: 14

[42.] ChandyS, et al. . Evaluation of C-Reactive Protein and Fibrinogen in Patients with Chronic and Aggressive Periodontitis: A Clinico-Biochemical Study. J. Clin. Diagn. Res., 2017, 11: ZC41-ZC45

[43.] ArvanitidisE, BizzarroS, Alvarez RodriguezE, LoosBG, NicuEA. Reduced platelet hyper-reactivity and platelet-leukocyte aggregation after periodontal therapy. Thromb. J., 2017, 15: 5

[44.] VidalF, CordovilI, FigueredoCM, FischerRG. Non-surgical periodontal treatment reduces cardiovascular risk in refractory hypertensive patients: a pilot study. J. Clin. Periodontol., 2013, 40: 681-687

[45.] MatthewsJB, WrightHJ, RobertsA, CooperPR, ChappleIL. Hyperactivity and reactivity of peripheral blood neutrophils in chronic periodontitis. Clin. Exp. Immunol., 2007, 147: 255-264

[46.] SternbergZ, et al. . Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood. Atherosclerosis, 2013, 229: 338-347

[47.] SchenkeinHA, PapapanouPN, GencoR, SanzM. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000, 2020, 83: 90-106

[48.] HerreraD, MolinaA, BuhlinK, KlingeB. Periodontal diseases and association with atherosclerotic disease. Periodontol 2000, 2020, 83: 66-89

[49.] Salehi OmranS, HartmanA, ZakaiNA, NaviBB. Thrombophilia Testing After Ischemic Stroke: Why, When, and What?. Stroke, 2021, 52: 1874-1884

[50.] MendelsonSJ, PrabhakaranS. Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review. JAMA, 2021, 325: 1088-1098

[51.] BrunA, et al. . Oral microbiota and atherothrombotic carotid plaque vulnerability in periodontitis patients. A cross-sectional study. J. Periodontal Res, 2021, 56: 339-350

[52.] BobetsisYA, et al. . Association between periodontal disease and vulnerable plaque morphology in patients undergoing carotid endarterectomy. Int J. Cardiol. Heart Vasc., 2020, 30: 100601

[53.] RodeanIP, et al. . Periodontal Disease Is Associated with Increased Vulnerability of Coronary Atheromatous Plaques in Patients Undergoing Coronary Computed Tomography Angiography-Results from the Atherodent Study. J. Clin. Med., 2021, 10: 1290

[54.] ChoDH, SongIS, ChoiJ, GwonJG. Risk of peripheral arterial disease in patients with periodontitis: A nationwide, population-based, matched cohort study. Atherosclerosis, 2020, 297: 96-101

[55.] WangJ, et al. . The risk of periodontitis for peripheral vascular disease: a systematic review. Rev. Cardiovasc Med., 2019, 20: 81-89

[56.] OlinJW, ShihA. Thromboangiitis obliterans (Buerger’s disease). Curr. Opin. Rheumatol., 2006, 18: 18-24

[57.] RahmanM, ChowdhuryAS, FukuiT, HiraK, ShimboT. Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: a case-control study. Int J. Epidemiol., 2000, 29: 266-270

[58.] OlinJW. Thromboangiitis obliterans (Buerger’s disease). N. Engl. J. Med, 2000, 343: 864-869

[59.] IwaiT, et al. . Oral bacteria in the occluded arteries of patients with Buerger disease. J. Vasc. Surg., 2005, 42: 107-115

[60.] IgariK, InoueY, IwaiT. The Epidemiologic and Clinical Findings of Patients with Buerger Disease. Ann. Vasc. Surg., 2016, 30: 263-269

[61.] ChenYW, et al. . Elevated IgG titers to periodontal pathogens related to Buerger disease. Int J. Cardiol., 2007, 122: 79-81

[62.] ChenYW, et al. . Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J. Clin. Periodontol., 2009, 36: 830-835

[63.] IwaiT, UmedaM, InoueY. Are There Any Objections against Our Hypothesis That Buerger Disease Is an Infectious Disease?. Ann. Vasc. Dis., 2012, 5: 300-309

[64.] JoglarJA, et al. . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2024, 149: e1-e156

[65.] MiyauchiS, et al. . Periodontitis and the outcome of atrial fibrillation ablation: Porphyromonas gingivalis is related to atrial fibrillation recurrence. J. Cardiovasc Electrophysiol., 2021, 32: 1240-1250

[66.] MiyauchiS, et al. . Porphyromonas gingivalis and left atrial appendage spontaneous echo contrast in atrial fibrillation ablation candidates. Heart Vessels, 2021, 36: 1721-1729

[67.] ImSI, et al. . Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation. Open Heart, 2018, 5: e000708

[68.] SenS, et al. . Periodontal Disease, Atrial Fibrillation and Stroke. Am. Heart J., 2021, 235: 36-43

[69.] HsiaoYW, HuangJW. Myocardial ischemia 10 years after a modified Cabrol procedure in a 42-year-old patient with Marfan syndrome. BMC Cardiovasc Disord., 2020, 20: 461

[70.] Delgado, M. G., Riesco, N., Murias, E. & Calleja, S. Acute cervical artery dissection after a dental procedure due to a second inferior molar infection. BMJ Case Rep.2015, bcr2015210348 (2015).

[71.] MilewiczDM, et al. . Marfan syndrome. Nat. Rev. Dis. Prim., 2021, 7: 64

[72.] UmezawaK, et al. . A case series describing the risk of periodontal disease in Marfan syndrome patients harboring a possible aortic aneurysm or dissection. BMC Oral. Health, 2022, 22

[73.] ZhangY, YuanYQ. Value of left atrial diameter with CHA2DS2-VASc score in predicting left atrial/left atrial appendage thrombosis in non-valvular atrial fibrillation. Arq. Bras. Cardiol., 2021, 116: 325-331

[74.] KarabanK, et al. . Coagulation Disorders and Thrombotic Complications in Heart Failure With Preserved Ejection Fraction. Curr. Probl. Cardiol., 2024, 49: 102127

[75.] KuriharaN, et al. . Oral bacteria are a possible risk factor for valvular incompetence in primary varicose veins. Eur. J. Vasc. Endovasc. Surg., 2007, 34: 102-106

[76.] Sanchez-SilesM, Rosa-SalazarV, Camacho-AlonsoF, Salazar-SanchezN, Cozar-HidalgoJ. Association between periodontal disease and venous thromboembolic disease. Quintessence Int, 2013, 44: 567-573

[77.] Sanchez-SilesM, Rosa-SalazarV, Salazar-SanchezN, Camacho-AlonsoF. Periodontal disease as a risk factor of recurrence of venous thromboembolic disease: a prospective study. Acta Odontol. Scand., 2015, 73: 8-13

[78.] CowanLT, et al. . Periodontal disease and incident venous thromboembolism: The Atherosclerosis Risk in Communities study. J. Clin. Periodontol., 2019, 46: 12-19

[79.] DeviOM, GuptaJ, ChahalGS, JainA. Is periodontal infection a risk factor for thromboembolic disease? A systematic review. J. Indian Soc. Periodontol., 2023, 27: 238-250

[80.] HiraiJ, et al. . Lemierre Syndrome Due to Dialister pneumosintes: A Case Report. Infect. Drug Resist., 2022, 15: 2763-2771

[81.] TezukaT, et al. . Cerebral Venous Thrombosis Mimicking Limbic Encephalitis. Intern Med., 2024, 63: 1277-1280

[82.] PaulK, PatelSS. Eikenella corrodens infections in children and adolescents: case reports and review of the literature. Clin. Infect. Dis., 2001, 33: 54-61

[83.] YeR, ZhaoL, WangC, WuX, YanH. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir. Med., 2014, 108: 1-8

[84.] MattarCS, KeithRL, ByrdRPJr., RoyTM. Septic pulmonary emboli due to periodontal disease. Respir. Med., 2006, 100: 1470-1474

[85.] CastroDV, CostaS, GomesO, FerreiraN, PereiraL. Septic Embolism Associated With Periodontal Disease: A Case Report. Cureus, 2023, 15: e40468

[86.] WatanabeT, YokoeM, NoguchiY. Septic pulmonary embolism associated with periodontal disease: a case report and literature review. BMC Infect. Dis., 2019, 19

[87.] WangQ, ZhaoL, XuC, ZhouJ, WuY. Fusobacterium nucleatum stimulates monocyte adhesion to and transmigration through endothelial cells. Arch. Oral. Biol., 2019, 100: 86-92

[88.] ZhouJ, LiuL, WuP, ZhaoL, WuY. Fusobacterium nucleatum Accelerates Atherosclerosis via Macrophage-Driven Aberrant Proinflammatory Response and Lipid Metabolism. Front Microbiol., 2022, 13: 798685

[89.] OkaK, et al. . Clival Osteomyelitis with Cavernous Sinus Thrombosis Due to Fusobacterium nucleatum and Campylobacter rectus Induced by Tooth Extraction. Intern Med., 2018, 57: 3325-3328

[90.] ShiotaY, et al. . Septic pulmonary embolism induced by dental infection. Acta Med Okayama, 2013, 67: 253-258

[91.] HataniT, et al. . Septic pulmonary embolism due to periodontal disease. Respirology, 2013, 18: 308-312

[92.] EmmiG, et al. . Thrombosis in vasculitis: from pathogenesis to treatment. Thromb. J., 2015, 13: 15

[93.] SeyahiE. Behcet’s disease: How to diagnose and treat vascular involvement. Best. Pr. Res Clin. Rheumatol., 2016, 30: 279-295

[94.] BettiolA, et al. . Vascular Behcet syndrome: from pathogenesis to treatment. Nat. Rev. Rheumatol., 2023, 19: 111-126

[95.] Celenligil-NazlielH, KansuE, EbersoleJL. Periodontal findings and systemic antibody responses to oral microorganisms in Behcet’s disease. J. Periodontol., 1999, 70: 1449-1456

[96.] AkmanA, KacarogluH, DonmezL, BacanliA, AlpsoyE. Relationship between periodontal findings and Behcet’s disease: a controlled study. J. Clin. Periodontol., 2007, 34: 485-491

[97.] AkmanA, et al. . Relationship between periodontal findings and specific polymorphisms of interleukin-1alpha and -1beta in Turkish patients with Behcet’s disease. Arch. Dermatol Res., 2008, 300: 19-26

[98.] AkmanA, et al. . Relationship between periodontal findings and the TNF-alpha Gene 1031 T/C polymorphism in Turkish patients with Behcet’s disease. J. Eur. Acad. Dermatol Venereol., 2008, 22: 950-957

[99.] ArabaciT, KaraC, CicekY. Relationship between periodontal parameters and Behcet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis. J. Periodontal Res., 2009, 44: 718-725

[100.] KaracayliU, et al. . The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study. J. Oral. Pathol. Med., 2009, 38: 410-415

[101.] NakazawaD, MasudaS, TomaruU, IshizuA. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat. Rev. Rheumatol., 2019, 15: 91-101

[102.] BerdenAE, et al. . Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis. J. Am. Soc. Nephrol., 2010, 21: 2169-2179

[103.] AmesPR, MargaglioneM, MackieS, AlvesJD. Eosinophilia and thrombophilia in churg strauss syndrome: a clinical and pathogenetic overview. Clin. Appl Thromb. Hemost., 2010, 16: 628-636

[104.] MorganMD, et al. . Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum., 2009, 60: 3493-3500

[105.] NovoE, Garcia-MacGregorE, VieraN, ChaparroN, CrozzoliY. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study. J. Periodontol., 1999, 70: 185-188

[106.] EsbergA, et al. . Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Microorganisms, 2022, 10: 1572

[107.] VieraNT, Rojas-de-MoralesT, NavasRM, ZambranoOR, Paz-de-GudinoM. Gingivitis and anti-neutrophil cytoplasmic antibodies in children and adolescents suffering from Leukemia. Med Oral. Patol. Oral. Cir. Bucal, 2004, 9: 399-402396-398

[108.] UnluO, ZuilyS, ErkanD. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur. J. Rheumatol., 2016, 3: 75-84

[109.] MiyakisS, et al. . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost., 2006, 4: 295-306

[110.] CerveraR, et al. . Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis., 2015, 74: 1011-1018

[111.] SevimE, et al. . Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res. (Hoboken), 2022, 74: 324-335

[112.] KnightJS, BranchDW, OrtelTL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ, 2023, 380: e069717

[113.] Garcia-CarrascoM, et al. . The role of infectious diseases in the catastrophic antiphospholipid syndrome. Autoimmun. Rev., 2015, 14: 1066-1071

[114.] SchenkeinHA, ThomasRR. Anticardiolipin (aCL) in sera from periodontitis subjects activate Toll-like receptor 4 (TLR4). PLoS One, 2018, 13: e0203494

[115.] SchenkeinHA, BradleyJL, PurkallDB. Anticardiolipin in porphyromonas gingivalis antisera causes fetal loss in mice. J. Dent. Res., 2013, 92: 814-818

[116.] WangD, et al. . Molecular mimicry of Aggregatibacter actinomycetemcomitans with beta2 glycoprotein I. Oral. Microbiol Immunol., 2008, 23: 401-405

[117.] DegrelleSA, GerbaudP, LeconteL, FerreiraF, PidouxG. Annexin-A5 organized in 2D-network at the plasmalemma eases human trophoblast fusion. Sci. Rep., 2017, 7

[118.] van GenderenHO, KenisH, HofstraL, NarulaJ, ReutelingspergerCP. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys. Acta, 2008, 1783: 953-963

[119.] RandJH, et al. . Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a “lupus procoagulant” phenomenon. Blood, 1998, 92: 1652-1660

[120.] de LaatB, et al. . Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood, 2007, 109: 1490-1494

[121.] SchenkeinHA, ThomasRR. Anticardiolipin from Periodontitis Patients Impact Fetal Loss and Annexin V. J. Dent. Res., 2020, 99: 797-803

[122.] BizzarroS, NicuEA, van der VeldenU, LaineML, LoosBG. Association of serum immunoglobulin G (IgG) levels against two periodontal pathogens and prothrombotic state: a clinical pilot study. Thromb. J., 2010, 8: 16

[123.] RangeH, et al. . Periodontal bacteria in human carotid atherothrombosis as a potential trigger for neutrophil activation. Atherosclerosis, 2014, 236: 448-455

[124.] Pinon-EstebanP, et al. . Presence of bacterial DNA in thrombotic material of patients with myocardial infarction. Sci. Rep., 2020, 10

[125.] JoshiC, et al. . Detection of periodontal microorganisms in coronary atheromatous plaque specimens of myocardial infarction patients: A systematic review and meta-analysis. Trends Cardiovasc Med., 2021, 31: 69-82

[126.] Ko, L.-C., Tang, S.-C. & Jeng, J.-S. Periodontitis Associated With Septic Lateral Sinus Thrombosis and Pulmonary Embolism. (2015).

[127.] VakhitovD, et al. . Bacterial signatures in thrombus aspirates of patients with lower limb arterial and venous thrombosis. J. Vasc. Surg., 2018, 67: 1902-1907

[128.] ZhanY, et al. . The role of platelets in inflammatory immune responses in generalized aggressive periodontitis. J. Clin. Periodontol., 2017, 44: 150-157

[129.] ZhangJ, et al. . Interactions of periodontal pathogens with platelets in the gingival crevicular fluid of patients with periodontitis. J. Clin. Periodontol., 2022, 49: 922-931

[130.] AssingerA, et al. . Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2. J. Thromb. Haemost., 2011, 9: 799-809

[131.] AssingerA, LakyM, BadrnyaS, EsfandeyariA, VolfI. Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4. Thromb. Res, 2012, 130: e73-e78

[132.] LiX, et al. . An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation. Thromb. Res., 2008, 122: 810-819

[133.] ChenWA, FletcherHM, GheorgheJD, OyoyoU, BoskovicDS. Platelet plug formation in whole blood is enhanced in the presence of Porphyromonas gingivalis. Mol. Oral. Microbiol., 2020, 35: 251-259

[134.] AssingerA, et al. . Periodontopathogens induce soluble P-selectin release by endothelial cells and platelets. Thromb. Res., 2011, 127: e20-e26

[135.] LakyM, et al. . Decreased phosphorylation of platelet vasodilator-stimulated phosphoprotein in periodontitis–a role of periodontal pathogens. Thromb. Res, 2011, 128: 155-160

[136.] RothGA, et al. . Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J. Thromb. Haemost., 2006, 4: 2256-2261

[137.] RothGA, et al. . Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. Thromb. Res., 2009, 123: 780-784

[138.] TemelliB, et al. . Platelet indices (mean platelet volume and platelet distribution width) have correlations with periodontal inflamed surface area in coronary artery disease patients: A pilot study. J. Periodontol., 2018, 89: 1203-1212

[139.] NicuEA, Van der VeldenU, NieuwlandR, EvertsV, LoosBG. Elevated platelet and leukocyte response to oral bacteria in periodontitis. J. Thromb. Haemost., 2009, 7: 162-170

[140.] KubotaT, et al. . Arterial thrombosis after intravenous infusion of oral bacterium in a rat model. Ann. Vasc. Surg., 2008, 22: 412-416

[141.] YuKM, et al. . The periodontal anaerobe Porphyromonas gingivalis induced platelet activation and increased aggregation in whole blood by rat model. Thromb. Res., 2011, 127: 418-425

[142.] SilvaNLC, et al. . Periodontal status, vascular reactivity, and platelet aggregation changes in rats submitted to hypercholesterolemic diet and periodontitis. J. Periodontal Res., 2020, 55: 453-463

[143.] IwaiT, et al. . Oral-bacterial-induced arterial and venous thrombus in rats: Pathological and immunological studies. Clin. Exp. Dent. Res., 2019, 5: 497-504

[144.] IwaiT, et al. . Pathological and immunological differences of arterial thrombi and wall caused by three different periodontal bacterial injections in rat models and proposals on the pathogeneses of vascular diseases. Clin. Exp. Dent. Res., 2021, 7: 637-646

[145.] AmarS, et al. . Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb. Vasc. Biol., 2003, 23: 1245-1249

[146.] DoringY, SoehnleinO, WeberC. Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis. Circ. Res., 2017, 120: 736-743

[147.] RieggerJ, et al. . Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium. Eur. Heart J., 2016, 37: 1538-1549

[148.] SavchenkoAS, et al. . Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J. Thromb. Haemost., 2014, 12: 860-870

[149.] EtulainJ, et al. . P-selectin promotes neutrophil extracellular trap formation in mice. Blood, 2015, 126: 242-246

[150.] MaugeriN, et al. . Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J. Thromb. Haemost., 2014, 12: 2074-2088

[151.] StarkK, et al. . Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood, 2016, 128: 2435-2449

[152.] HirschfeldJ, et al. . Neutrophil extracellular trap formation in supragingival biofilms. Int J. Med. Microbiol., 2015, 305: 453-463

[153.] WhiteP, et al. . Peripheral blood neutrophil extracellular trap production and degradation in chronic periodontitis. J. Clin. Periodontol., 2016, 43: 1041-1049

[154.] WhitePC, ChiccaIJ, CooperPR, MilwardMR, ChappleIL. Neutrophil Extracellular Traps in Periodontitis: A Web of Intrigue. J. Dent. Res, 2016, 95: 26-34

[155.] LuoL, et al. . Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis. Arch. Oral. Biol., 2011, 56: 1106-1111

[156.] SrisuwanthaR, et al. . Porphyromonas Gingivalis Elevated High-Mobility Group Box 1 Levels After Myocardial Infarction in Mice. Int Heart J., 2017, 58: 762-768

[157.] WislerJW, BeckerRC. Emerging paradigms in arterial thrombosis. J. Thromb. Thrombolysis, 2014, 37: 4-11

[158.] KannemeierC, et al. . Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc. Natl Acad. Sci. USA, 2007, 104: 6388-6393

[159.] NakazawaF, et al. . Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J., 2005, 385: 831-838

[160.] MonroeDM. Polyphosphates rock! A role in thrombosis?. Blood, 2015, 126: 1403-1404

[161.] PanigrahiS, et al. . Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ. Res, 2013, 112: 103-112

[162.] El-SayedOM, et al. . Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. J. Vasc. Surg., 2016, 64: 1450-1458 e1451

[163.] MedeirosSK, et al. . Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?. Thromb. Res, 2020, 186: 13-19

[164.] PreissnerKT, HerwaldH. Extracellular nucleic acids in immunity and cardiovascular responses: between alert and disease. Thromb. Haemost., 2017, 117: 1272-1282

[165.] ZhuX, et al. . The Correlation between Periodontal Parameters and Cell-Free DNA in the Gingival Crevicular Fluid, Saliva, and Plasma in Chinese Patients: A Cross-Sectional Study. J. Clin. Med., 2022, 11: 6902

[166.] HuangH, et al. . Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis. Nat. Commun., 2022, 13

[167.] CrumpKE, SahingurSE. Microbial Nucleic Acid Sensing in Oral and Systemic Diseases. J. Dent. Res., 2016, 95: 17-25

[168.] LiuJ, et al. . Mitochondrial DNA Efflux Maintained in Gingival Fibroblasts of Patients with Periodontitis through ROS/mPTP Pathway. Oxid. Med Cell Longev., 2022, 2022: 1000213

[169.] TakeshitaA, ImaiK, HanazawaS. CpG motifs in Porphyromonas gingivalis DNA stimulate interleukin-6 expression in human gingival fibroblasts. Infect. Immun., 1999, 67: 4340-4345

[170.] NeilandsJ, KinnbyB. Porphyromonas gingivalis initiates coagulation and secretes polyphosphates - A mechanism for sustaining chronic inflammation?. Micro. Pathog., 2022, 162: 104648

[171.] BaoJ, et al. . Periodontitis may induce gut microbiota dysbiosis via salivary microbiota. Int J. Oral. Sci., 2022, 14: 32

[172.] ParkS, et al. . Oral Porphyromonas gingivalis infection affects intestinal microbiota and promotes atherosclerosis. J. Clin. Periodontol., 2023, 50: 1553-1567

[173.] XiaoL, et al. . Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice. Front Cell Infect. Microbiol, 2021, 11: 820535

[174.] HuangY, et al. . Non-surgical Periodontal Treatment Restored the Gut Microbiota and Intestinal Barrier in Apolipoprotein E(-/-) Mice With Periodontitis. Front Cell Infect. Microbiol, 2020, 10: 498

[175.] ZhuW, et al. . Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell, 2016, 165: 111-124

[176.] GongD, et al. . Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients. Am. J. Med Sci., 2019, 358: 422-428

[177.] NemetI, et al. . A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell, 2020, 180: 862-877.e822

[178.] HuangK, et al. . Gut microbial co-metabolite 2-methylbutyrylcarnitine exacerbates thrombosis via binding to and activating integrin alpha2beta1. Cell Metab., 2024, 36: 598-616.e599

[179.] PattiG, et al. . Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs. Nat. Rev. Cardiol., 2019, 16: 113-130

[180.] BitencourtFV, et al. . Co-occurrence of Periodontitis and Diabetes-Related Complications. J. Dent. Res., 2023, 102: 1088-1097

[181.] SalhiL, RenersM. Update on the Bidirectional Link Between Diabetes and Periodontitis. Adv. Exp. Med Biol., 2022, 1373: 231-240

[182.] LallaE, PapapanouPN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat. Rev. Endocrinol., 2011, 7: 738-748

[183.] ChengY, et al. . Impact of hyperglycaemia on complications in patients who had a stroke after thrombolysis. Postgrad. Med. J., 2021, 97: 792-797

[184.] HaidaraMA, Al-AniB, Bin-JaliahI, Shams EldeenAM, MorsyMD. Vanadyl sulphate ameliorates biomarkers of endothelial injury and coagulation and thrombosis in a rat model of hyperglycaemia. Arch. Physiol. Biochem, 2022, 128: 447-454

[185.] KakourosN, RadeJJ, KourliourosA, ResarJR. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J. Endocrinol., 2011, 2011: 742719

[186.] AlzahraniSH, AjjanRA. Coagulation and fibrinolysis in diabetes. Diab Vasc. Dis. Res., 2010, 7: 260-273

[187.] PretoriusL, et al. . Platelet activity and hypercoagulation in type 2 diabetes. Cardiovasc Diabetol., 2018, 17: 141

[188.] GarianiK, MavrakanasT, CombescureC, PerrierA, MartiC. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. Eur. J. Intern Med., 2016, 28: 52-58

[189.] BellEJ, et al. . Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. Diabetes Res. Clin. Pr., 2016, 111: 10-18

[190.] NuhrenbergTG, et al. . Uncontrolled Diabetes Mellitus Has No Major Influence on the Platelet Transcriptome. Biomed. Res. Int., 2018, 2018: 8989252

[191.] LeeH, et al. . Single-cell analysis of platelets from patients with periodontitis and diabetes. Res Pr. Thromb. Haemost., 2023, 7: 100099

[192.] NordanstigJ, et al. . Editor’s Choice – European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur. J. Vasc. Endovasc. Surg., 2024, 67: 9-96

[193.] TwineCP, et al. . Editor’s Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy for Vascular Diseases. Eur. J. Vasc. Endovasc. Surg., 2023, 65: 627-689

[194.] LymanGH, et al. . American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv., 2021, 5: 927-974

[195.] NakanishiK, et al. . Effects of intermittent pneumatic compression of the thigh on blood flow velocity in the femoral and popliteal veins: developing a new physical prophylaxis for deep vein thrombosis in patients with plaster-cast immobilization of the leg. J. Thromb. Thrombolysis, 2016, 42: 579-584

[196.] GardnerAM, et al. . Reduction of post-traumatic swelling and compartment pressure by impulse compression of the foot. J. Bone Jt. Surg. Br., 1990, 72: 810-815

[197.] MolaniaT, et al. . Oral health-related quality of life (OHRQoL) in cardiovascular patients referring to Fatima Zahra Hospital in Sari, Iran. BMC Oral. Health, 2021, 21

[198.] RenvertS, OhlssonO, PetterssonT, PerssonGR. Periodontitis: a future risk of acute coronary syndrome? A follow-up study over 3 years. J. Periodontol., 2010, 81: 992-1000

[199.] DornJM, et al. . Periodontal disease and recurrent cardiovascular events in survivors of myocardial infarction (MI): the Western New York Acute MI Study. J. Periodontol., 2010, 81: 502-511

[200.] ReichertS, et al. . Is Periodontitis a Predictor for an Adverse Outcome in Patients Undergoing Coronary Artery Bypass Grafting? A Pilot Study. J. Clin. Med., 2021, 10: 818

[201.] Duda-SobczakA, et al. . Association of skin autofluorescence with periodontal inflammation in adults with type 1 diabetes. Pol. Arch. Intern Med., 2017, 127: 708-711

[202.] ReichertS, et al. . Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG). J. Clin. Med., 2022, 11: 4105

[203.] FukushimaT, et al. . Effect of Periodontal Disease on Long-Term Outcomes After Percutaneous Coronary Intervention for De Novo Coronary Lesions in Non-Smokers. Circ. J., 2022, 86: 811-818

[204.] NagyFT, et al. . Oral Health of Patients Undergoing Percutaneous Coronary Intervention-A Possible Link between Periodontal Disease and In-Stent Restenosis. J. Pers. Med., 2023, 13: 760

[205.] WuY, et al. . Association between oral infections, triglyceride-glucose index, and in-stent restenosis. Oral. Dis., 2023, 29: 3698-3706

[206.] BellesiniM, et al. . D-dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta-analysis. J. Thromb. Haemost., 2021, 19: 2454-2467

[207.] DikshitS. Fibrinogen Degradation Products and Periodontitis: Deciphering the Connection. J. Clin. Diagn. Res., 2015, 9: ZC10-ZC12

[208.] TaylorBA, et al. . Full-mouth tooth extraction lowers systemic inflammatory and thrombotic markers of cardiovascular risk. J. Dent. Res., 2006, 85: 74-78

[209.] GualteroDF, et al. . Oral microbiome mediated inflammation, a potential inductor of vascular diseases: a comprehensive review. Front Cardiovasc Med, 2023, 10: 1250263

[210.] CalabroP, WillersonJT, YehET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation, 2003, 108: 1930-1932

[211.] MegsonE, FitzsimmonsT, DharmapatniK, BartoldPM. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J. Clin. Periodontol., 2010, 37: 797-804

[212.] MachadoV, et al. . Serum C-Reactive Protein and Periodontitis: A Systematic Review and Meta-Analysis. Front Immunol., 2021, 12: 706432

[213.] OffenbacherS, et al. . Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J. Periodontol., 2009, 80: 190-201

[214.] TonettiMS, et al. . Treatment of periodontitis and endothelial function. N. Engl. J. Med., 2007, 356: 911-920

[215.] GugnaniN, GugnaniS. Can treatment of severe periodontitis in patients with ST-segment elevation myocardial infarction improve endothelial function?. Evid. Based Dent., 2021, 22: 5-7

[216.] LoboMG, et al. . Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial. Eur. J. Intern Med., 2020, 71: 76-80

[217.] BokhariSA, et al. . Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J. Clin. Periodontol., 2012, 39: 1065-1074

[218.] LakyM, et al. . Periodontal treatment does not result in detectable platelet activation in vivo. Clin. Oral. Investig., 2020, 24: 1853-1859

[219.] LakyM, et al. . Periodontal treatment limits platelet activation in patients with periodontitis-a controlled-randomized intervention trial. J. Clin. Periodontol., 2018, 45: 1090-1097

[220.] ChastonR, SabatiniR, KoertgeTE, BrooksCN, SchenkeinHA. Serum anticardiolipin concentrations in patients with chronic periodontitis following scaling and root planing. J. Periodontol., 2014, 85: 683-687

[221.] SeinostG, et al. . Periodontal treatment and vascular inflammation in patients with advanced peripheral arterial disease: A randomized controlled trial. Atherosclerosis, 2020, 313: 60-69

[222.] GabrioneF, ObertiL, NardoneM, Di GirolamoM. Why patients with cardiovascular risks go to dentists. Is there sufficient evidence of influence of periodontal therapy on cardiovascular disease?. J. Biol. Regul. Homeost. Agents, 2019, 33: 113-119

[223.] ParkJH, ChangY, KimJW, SongTJ. Improved Oral Health Status Is Associated with a Lower Risk of Venous Thromboembolism: A Nationwide Cohort Study. J. Pers. Med., 2022, 13: 20

[224.] JacobiN, et al. . The Association of Periodontitis and Peripheral Arterial Occlusive Disease in a Prospective Population-Based Cross-Sectional Cohort Study. J. Clin. Med., 2021, 10: 2048

[225.] AarabiG, et al. . Periodontal treatment and peripheral arterial disease severity - a retrospective analysis of health insurance claims data. Vasa, 2020, 49: 128-132